(+)-2-(1-hydroxyl-4-oxocyclohexyl) ethyl caffeate (HOEC) was isolated from Incarvillea mairei var. granditlora (Wehrhahn) Grierson. The plants of the Incarvillea genus have long been used as folk medicines for the treatment of inflammation-related diseases in China. 5-Lipoxygenase (5-LOX), a key enzyme in the arachidonic acid (AA) cascade, was identified as a potential target of HOEC by a pulldown assay, and then extensively validated by biosensor-based affinity detection, enzyme-based activity assays, cell-based AA metabolite analysis and computer-aided AA network simulation. Further in vivo studies of AA-induced ear oedema, ovalbumin (OVA)-induced lung inflammation and collagen-induced arthritis demonstrated the anti-inflammatory potency and validated the therapeutic target of HOEC. This work revealed that HOEC acted as an anti-inflammatory agent targeting 5-LOX, which not only confirmed the key role of 5-LOX in inflammation but also provided a paradigm for the exploration of natural product mechanisms of action.
LindsayMA. Target discovery. Nat Rev Drug Discov2003; 2:831–8.
2.
TitovDVLiuJO. Identification and validation of protein targets of bioactive small molecules. Bioorg Med Chem2012; 20:1902–9.
3.
ChoCHNuttallME. Emerging techniques for the discovery and validation of therapeutic targets for skeletal diseases. Expert Opin Ther Targets2002; 6:679–89.
4.
Aoki-KinoshitaKFKanehisaM. Bioinformatics approaches in glycomics and drug discovery. Curr Opin Mol Ther2006; 8:514–20.
5.
HirotaTLewisaWGLiuaACLeeJWSchultzPGKaySA. A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3. Proc Natl Acad Sci USA2008; 105:20746–51.
6.
JeongCHBodeAMPuglieseA. [6]-Gingerol suppresses colon cancer growth by targeting leukotriene A4 hydrolase. Cancer Res2009; 69:5584–91.
7.
FunkCD. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science2001; 294:1871–5.
8.
PergolaCWerzO. 5-Lipoxygenase inhibitors: A review of recent developments and patents. Expert Opin Ther Pat2010; 20:355–75.
9.
GriffithsRJPettipherERKochK. Leukotriene B4 plays a critical role in the progression of collagen-induced arthritis. Proc Natl Acad Sci USA1995; 92:517–21.
10.
IsraelECohnJDubéL. Effect of treatment with zileuton, a 5-lipoxygenase inhibitor, in patients with asthma. J Am Med Assoc1996; 275:931–6.
11.
ChoiJHJeonHJParkJG. Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperl ipidemic mice. Atherosclerosis2010; 212:146–52.
12.
AmaralFACostaVVTavaresLD. NLRP3 inflammasome-mediated neutrophil recruitment and hypernociception depend on leukotriene B4 in a murine model of gout. Arthritis Rheum2012; 64:474–84.
13.
WerzOSteinhilberD. Therapeutic options for 5-lipoxygenase inhibitors. Pharmacol Ther2006; 112:701–18.
14.
Peters-GoldenMDHendersonWR. Leukotrienes. N Engl J Med2007; 357:1841–54.
15.
US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). Guidance for Adverse Event Reporting Program Safety Information, 1996.
16.
ChenXSShelterJRJohnsonENFunkCD. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature1994; 372:179–82.
17.
ByrumRSGouletJLSnouwaertJNGriffithsRJKollerBH. Determination of the contribution of cysteinyl leukotrienes and leukotriene B4 in acute inflammatory responses using 5-lipoxygenase-and leukotriene A4 hydrolase-deficient mice. J Immunol1999; 163:6810–9.
18.
Editor Board of Chinese Materia Medica of the state Administration of Traditional Chinese Medicine. Chinese Materia Medica. Shanghai Science and Technology Publisher, Shanghai1999; 7:426–27.
19.
SuYQZhangWDZhangCLiuRHShenYH. A new caffeic ester from Incarvillea mairei var. granditlora (Wehrhahn) Grierson. Chinese Chem Lett2008; 19:829–31.
20.
YuanHHanWYangZWShanLZhangWDSunQY. Total Synthesis of Natural Product (+)-2-(1-hydroxyl-4-oxocyclohexyl)ethyl caffeate as a Modulator of Leukotriene A4 Hydrolase. Huaxue Xuebao2011; 22:2691–5.
21.
GronewoldTM. Surface acoustic wave sensors in the bioanalytical field: Recent trends and challenges. Anal Chim Acta2007; 603:119–28.
22.
ZengHDouSZhaoJFanSYuanXZhuSLiLZhangWLiuR. The inhibitory activities of the components of Huang-Lian-Jie-Du-Tang (HLJDT) on eicosanoid generation via lipoxygenase pathway. J Ethnopharmacol2011; 2:561–8.
YangKMaWLiangHOuyangQTangCLaiL. Dynamic simulations on the arachidonic acid metabolic network. PLoS Comput Biol2007; 3:523–30.
25.
RomasESimsNAHardsDK. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol2002; 161:1419–27.
26.
SchopfLSavinainenAAndersonK. IKK inhibition protects against bone and cartilage destruction in a rat model of rheumatoid arthritis. Arthritis Rheum2006; 54:3163–73.
27.
ConcepcionJWitteKWartchowC. Label-free detection of biomolecular interactions using BioLayer interferometry for kinetic characterization. Comb Chem High T Scr2009; 12:791–800.
28.
VargaftigBBSingerM. Leukotrienes mediate part of Ova-induced lung effects in mice via EGFR. Am J Physiol Lung Cell Mol Physiol2003; 285:808–18.
29.
RadmarkOWerzOSteinhilberDSamuelssonB. 5-Lipoxygenase: Regulation of expression and enzyme activity. Trends Biochem Sci2007; 32:332–41.
30.
RadmarkOSamuelssonB. 5-Lipoxygenase: Mechanisms of regulation. J Lipid Res2009; 50:40–5.
31.
SalaAFolcoGMurphyRC. Transcellular biosynthesis of eicosanoids. Pharmacol Rep2010; 62:503–10.
32.
SerhanCNJainAMarleauS. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol2003; 171:6856–65.
33.
YacoubianSSerhanCN. New endogenous antiinflammatory and proresolving lipid mediators: Implications for rheumatic diseases. Nat Clin Pract Rheumatol2007; 3:570–9.
